AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · Real-Time Price · USD
5.24
-0.03 (-0.57%)
At close: Jun 12, 2026, 4:00 PM EDT
5.32
+0.08 (1.53%)
After-hours: Jun 12, 2026, 7:52 PM EDT
AbCellera Biologics Market Cap
AbCellera Biologics has a market cap or net worth of $1.6 billion as of June 12, 2026. Its market cap has increased by 162.70% in one year.
Market Cap
1.60B
Enterprise Value
1.23B
1-Year Change
162.70%
Ranking
Category
Stock Price
$5.24
Market Cap Chart
Since the IPO on December 11, 2020, AbCellera Biologics's market cap has decreased from $15.66B to $1.60B, a decrease of -89.79%. That is a compound annual growth rate of -33.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 1.60B | 56.25% |
| Dec 31, 2025 | 1.02B | 18.29% |
| Dec 31, 2024 | 865.42M | -47.77% |
| Dec 29, 2023 | 1.66B | -42.83% |
| Dec 30, 2022 | 2.90B | -28.02% |
| Dec 31, 2021 | 4.03B | -62.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Recursion Pharmaceuticals | 1.61B |
| Ascentage Pharma Group International | 1.61B |
| Sarepta Therapeutics | 1.60B |
| Nuvation Bio | 1.59B |
| Nurix Therapeutics | 1.58B |
| Syndax Pharmaceuticals | 1.56B |
| Taysha Gene Therapies | 1.55B |
| Fortrea Holdings | 1.55B |